iBio, Inc.
General ticker "IBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.3M (TTM average)
iBio, Inc. does not follow the US Stock Market performance with the rate: -12.7%.
Estimated limits based on current volatility of 7.6%: low 1.04$, high 1.21$
Factors to consider:
- Total employees count: 16 as of 2023
- Top business risk factors: Substantial doubt about viability, Need for additional capital, Limited operating history, High R&D costs, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [0.47$, 1.62$]
- 2026-06-30 to 2027-06-30 estimated range: [0.28$, 0.95$]
Financial Metrics affecting the IBIO estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -190.18 <= 0.33
- Positive: Investing cash flow per share per price, % of 9.22 > -0.66
- Positive: Shareholder equity ratio, % of 64.18 > 63.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term IBIO quotes
Long-term IBIO plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.23MM | $0.40MM |
| Operating Expenses | $29.34MM | $16.86MM | $19.00MM |
| Operating Income | $-29.34MM | $-16.63MM | $-18.60MM |
| Non-Operating Income | $0.03MM | $1.19MM | $0.23MM |
| Interest Expense | $0.08MM | $0.17MM | $0.21MM |
| R&D Expense | $10.33MM | $5.18MM | $8.31MM |
| Income(Loss) | $-29.31MM | $-15.44MM | $-18.38MM |
| Other Income(Loss) | $-35.70MM | $-9.46MM | $0.00MM |
| Profit(Loss)* | $-29.31MM | $-34.37MM | $-18.38MM |
| Stockholders Equity | $15.38MM | $21.32MM | $14.88MM |
| Assets | $41.21MM | $28.73MM | $23.18MM |
| Operating Cash Flow | $-30.44MM | $-18.55MM | $-15.30MM |
| Capital expenditure | $5.74MM | $0.21MM | $0.02MM |
| Investing Cash Flow | $7.01MM | $0.91MM | $0.74MM |
| Financing Cash Flow | $2.30MM | $24.49MM | $8.93MM |
| Earnings Per Share** | $-23.93 | $-8.97 | $-1.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.